1. Adigun M., Sliwa J.K., Turkoz I., et al. Impact of concomitant oral antidepressants on the efficacy and safety of esketamine nasal spray in patients with treatment-resistant depression. Poster presented at: US Psych Congress; October 3-6, 2019; San Diego, California.
2. Esketamine following transcranial magnetic stimulation for treatment resistant depression;Al-Sabbagh;Brain Stimul.,2022
3. Diagnostic and Statistical Manual of Mental Disorders: DSM-5,2013
4. Ketamine versus ECT for nonpsychotic treatment-resistant major depression;Anand;N. Engl. J. Med,2023
5. Effects of intranasal (s)-ketamine on veterans with co-morbid treatment-resistant depression and PTSD: a retrospective case series;Artin;eClinicalMedicine,2022